BVNXF (Bioventix) DeferredTaxAndRevenue: $0.00 Mil (As of Dec. 2025)


BVNXF Bioventix PLC BVNXF
62 GF Score
Price $14.71
GF Value $32.94
! 3 Warning Signs
View Full Analysis

What is Bioventix DeferredTaxAndRevenue?

Bioventix BVNXF 62 DeferredTaxAndRevenue is $0.00 Mil as of Dec. 2025. GuruFocus rates BVNXF with a GF Score™ of 62/100 and a GF Value™ of $32.94. The stock has 3 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Bioventix's current deferred tax and revenue for the quarter that ended in Dec. 2025 was $0.00 Mil.

Bioventix DeferredTaxAndRevenue Related Terms

Bioventix DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Bioventix's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioventix DeferredTaxAndRevenue Chart

Bioventix Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bioventix Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BVNXF
62GF Score
Bioventix PLC BVNXF
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.00 Mil mean?
Bioventix (BVNXF) has a DeferredTaxAndRevenue of $0.00 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Bioventix.
Is Bioventix's DeferredTaxAndRevenue too high?
Bioventix's current DeferredTaxAndRevenue is $0.00 Mil. Overall, Bioventix has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Bioventix's DeferredTaxAndRevenue compare to VRTX and REGN?
Bioventix's DeferredTaxAndRevenue of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Biotechnology company?
A good DeferredTaxAndRevenue depends on the Biotechnology industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Bioventix. Bioventix's current DeferredTaxAndRevenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioventix stock overvalued right now?
Bioventix (BVNXF) has a current DeferredTaxAndRevenue of $0.00 Mil. The stock's GF Value™ is $32.94, compared to a current price of $14.71 — trading 55.3% below its estimated fair value. The current DeferredTaxAndRevenue is $0.00 Mil. Bioventix's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Bioventix (BVNXF), the current DeferredTaxAndRevenue is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioventix (BVNXF) Overvalued in 2026?

Based on GuruFocus' analysis, Bioventix stock appears to be undervalued. The current stock price of $14.71 is trading 55.3% below its estimated GF Value™ of $32.94.

Key valuation signals for BVNXF:

  • DeferredTaxAndRevenue: $0.00 Mil
  • GF Value™: $32.94 vs. price of $14.71 (55.3% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the BVNXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioventix Business Description

Other Exchanges BVXP:UK51B:Germany
Address 27-28 Eastcastle Street, London, GBR, W1W 8DH
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.
62GF Score

Get the complete analysis for BVNXF

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.71
Price
$32.94
GF Value